Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Solid World Group S.p.A. ( (IT:S3D) ) has issued an update.
SolidWorld Group’s biomedical arm is set for a strategic consolidation as Bio3DModel and Bio3DPrinting move ahead with a reverse merger, expected to be effective from April 1, 2026 with retroactive accounting effects from January 1. The transaction marks the fourth step in the group’s corporate rationalization plan, designed to simplify its structure, reduce management complexity and create a single industrial platform that integrates anatomical modeling and 3D bioprinting capabilities. By concentrating skills, technology and commercial activities into one entity, SolidWorld aims to boost operational efficiency, strengthen governance of its biomedical division and better serve hospitals, research institutes and industrial partners seeking integrated solutions for advanced surgical planning and regenerative medicine. The merged biomedical division will function as a comprehensive platform covering the full value chain from clinical planning to translational research, enabling more advanced, patient-specific solutions and reinforcing the group’s positioning in personalized medicine, preclinical research and biomedical innovation, while ensuring continuity of operations for all existing activities.
The most recent analyst rating on (IT:S3D) stock is a Buy with a EUR1.55 price target. To see the full list of analyst forecasts on Solid World Group S.p.A. stock, see the IT:S3D Stock Forecast page.
More about Solid World Group S.p.A.
SolidWorld Group S.p.A., listed on Euronext Growth Milan, is an Italian technology group specializing in advanced 3D digital solutions integrated with artificial intelligence for industrial, biomedical and defense sectors. Through proprietary software and hardware, the company supports the transition to “Factory 5.0,” serving over 10,000 customers with 10 subsidiaries, 14 locations and three technology hubs, and is active in cutting-edge applications such as 3D bioprinting of human tissues and organs.
Average Trading Volume: 128,381
Technical Sentiment Signal: Sell
Current Market Cap: €15.66M
See more data about S3D stock on TipRanks’ Stock Analysis page.